84 related articles for article (PubMed ID: 1816671)
21. [Mycosis fungoides. Results of helioclimate therapy in high mountains (Davos, 1,560)].
Tippel H; Engst R
Hautarzt; 1986 Aug; 37(8):450-3. PubMed ID: 3759452
[TBL] [Abstract][Full Text] [Related]
22. Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.
Gerami P; Wickless SC; Rosen S; Kuzel TM; Ciurea A; Havey J; Guitart J
J Am Acad Dermatol; 2008 Aug; 59(2):245-54. PubMed ID: 18486274
[TBL] [Abstract][Full Text] [Related]
23. Mycosis fungoides d'embleé: CD30-negative cutaneous large T-cell lymphoma.
O'quinn RP; Zic JA; Boyd AS
J Am Acad Dermatol; 2000 Nov; 43(5 Pt 1):861-3. PubMed ID: 11050596
[TBL] [Abstract][Full Text] [Related]
24. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
[TBL] [Abstract][Full Text] [Related]
25. Autologous bone marrow transplantation for advanced stage mycosis fungoides.
Bigler RD; Crilley P; Micaily B; Brady LW; Topolsky D; Bulova S; Vonderheid EC; Brodsky I
Bone Marrow Transplant; 1991 Feb; 7(2):133-7. PubMed ID: 2049557
[TBL] [Abstract][Full Text] [Related]
26. High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma.
Marolleau JP; Baccard M; Flageul B; Rybojad M; Laroche L; Vérola O; Brandely M; Morel P; Gisselbrecht C
Arch Dermatol; 1995 May; 131(5):574-9. PubMed ID: 7741545
[TBL] [Abstract][Full Text] [Related]
27. [Folliculotropic mycosis fungoides. Study of four cases].
Gómez-Diez S; Maldonado C; Fueyo A; Vázquez-López F; Fresno MF; Pérez-Oliva N
Actas Dermosifiliogr; 2007 Sep; 98(7):486-90. PubMed ID: 17669304
[TBL] [Abstract][Full Text] [Related]
28. Mycosis fungoides palmaris et plantaris--an unusual variant of cutaneous T-cell lymphoma.
Topf S; Lüftl M; Neisius U; Brabletz T; Simon M; Schuler G; Schultz ES
Eur J Dermatol; 2006; 16(1):84-6. PubMed ID: 16436350
[TBL] [Abstract][Full Text] [Related]
29. Disease evolution of patients with mycosis fungoides--a report of 30 cases.
Berlingeri-Ramos AC; De Jesús G; Sánchez JL; González JR
P R Health Sci J; 2007 Jun; 26(2):151-4. PubMed ID: 17722429
[TBL] [Abstract][Full Text] [Related]
30. Bexarotene therapy for mycosis fungoides and Sézary syndrome.
Abbott RA; Whittaker SJ; Morris SL; Russell-Jones R; Hung T; Bashir SJ; Scarisbrick JJ
Br J Dermatol; 2009 Jun; 160(6):1299-307. PubMed ID: 19222457
[TBL] [Abstract][Full Text] [Related]
31. [Mycosis fungoides. Study of a series of 11 Tunisian cases].
Fazaa B; Goucha S; Zermani R; Zeglaoui F; Zghal M; Kennou H; Mezni F; Ezzine N; Kharfi M; Mokhtar I; Ben Jilani S; Kamoun MR
Tunis Med; 2002 Jan; 80(1):40-5. PubMed ID: 12071044
[TBL] [Abstract][Full Text] [Related]
32. [Modern therapy of mycosis fungoides].
Roenigk HH
Hautarzt; 1983 Jun; 34(6):266-72. PubMed ID: 6874333
[TBL] [Abstract][Full Text] [Related]
33. Total skin electron irradiation therapy in mycosis fungoides using high-dose rate mode: a preliminary experience.
Parida DK; Verma KK; Chander S; Joshi RC; Rath GK
Int J Dermatol; 2005 Oct; 44(10):828-30. PubMed ID: 16207183
[TBL] [Abstract][Full Text] [Related]
34. Retrospective 5-year review of 131 patients with mycosis fungoides and Sézary syndrome seen at the National Skin Centre, Singapore.
Tan ES; Tang MB; Tan SH
Australas J Dermatol; 2006 Nov; 47(4):248-52. PubMed ID: 17034466
[TBL] [Abstract][Full Text] [Related]
35. Uncommon presentation of mycosis fungoides: eyelid margin involvement.
Gül U; Soylu S; Aslan E; Yazar Z; Demiriz M
J Dermatol; 2008 Sep; 35(9):581-4. PubMed ID: 18837703
[TBL] [Abstract][Full Text] [Related]
36. Patient perspectives regarding the value of total skin electron beam therapy for cutaneous T-cell lymphoma/mycosis fungoides: a pilot study.
Yu JB; Khan AM; Jones GW; Reavely MM; Wilson LD
Am J Clin Oncol; 2009 Apr; 32(2):142-4. PubMed ID: 19307950
[TBL] [Abstract][Full Text] [Related]
37. Organ- and treatment-specific local response rates to systemic and local treatment modalities in stage IV melanoma.
Richtig E; Ludwig R; Kerl H; Smolle J
Br J Dermatol; 2005 Nov; 153(5):925-31. PubMed ID: 16225601
[TBL] [Abstract][Full Text] [Related]
38. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma.
Whittaker SJ; Foss FM
Cancer Treat Rev; 2007 Apr; 33(2):146-60. PubMed ID: 17275192
[TBL] [Abstract][Full Text] [Related]
40. Mycosis fungoides: cutaneous T-cell lymphoma.
Zaim MT; Grinkemeyer MD
Am Fam Physician; 1991 May; 43(5):1703-7. PubMed ID: 2021105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]